Clinical implications of plasma EGFR T790M and ctDNA shedding across metastatic sites in plasma- or tissue-confirmed EGFR-mutant non-small cell lung cancer treated with lazertinib: a prospective multicenter cohort study. - Kim MJ; Jung J; Ji W; Choi CM; Kim SJ; Cho HJ; Hwang YG; Kim EY; Lee SY; Yoo SS; Choi S; Oh IJ; et al. (Translational lung cancer research, 2026)